Indication
Liver cell carcinoma
Liver cell carcinoma, also known as hepatocellular carcinoma, is a primary malignancy of the digestive and hepatobiliary system that originates directly from hepatocytes. Read more about Liver cell carcinoma
21 drugs 14 manufacturers
Drugs that treat it
Common Liver cell carcinoma therapies.
NEXAVAR (sorafenib tosylate)
YERVOY (ipilimumab)
STIVARGA (regorafenib)
CYRAMZA (ramucirumab)
KEYTRUDA POWDER (pembrolizumab)
OPDIVO (nivolumab)
KEYTRUDA (pembrolizumab)
LENVIMA (lenvatinib mesylate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonLiver cell carcinoma, also known as hepatocellular carcinoma, is a primary malignancy of the digestive and hepatobiliary system that originates directly from hepatocytes.
It represents the predominant histological subtype of primary liver cancer and most commonly develops in older adults and individuals with underlying chronic hepatic disease.
Pathophysiologically, it typically arises in the setting of persistent hepatic inflammation, fibrosis, and cirrhosis driven by chronic hepatitis B or C viral infection, alcohol-associated liver disease, or metabolic dysfunction-associated steatohepatitis.
Clinical features frequently include right upper quadrant abdominal pain, hepatomegaly, jaundice, weight loss, or decompensation of preexisting cirrhosis, often alongside elevated serum alpha-fetoprotein levels.
- nih.gov
Liver cell carcinoma, also known as hepatocellular carcinoma, is a primary malignancy of the digestive and hepatobiliary system that originates directly from hepatocytes Pathophysiologically, it typically arises in the setting of persistent hepatic inflammation, fibrosis, and cirrhosis driven by chronic hepatitis B or C viral infection, alcohol-associated liver disease, or metabolic dysfunction-associated steatohepatitis Clinical features frequently include right upper quadrant abdominal pain, h...
- cancer.gov
Liver cell carcinoma, also known as hepatocellular carcinoma, is a primary malignancy of the digestive and hepatobiliary system that originates directly from hepatocytes Pathophysiologically, it typically arises in the setting of persistent hepatic inflammation, fibrosis, and cirrhosis driven by chronic hepatitis B or C viral infection, alcohol-associated liver disease, or metabolic dysfunction-associated steatohepatitis
- cancer.gov
It represents the predominant histological subtype of primary liver cancer and most commonly develops in older adults and individuals with underlying chronic hepatic disease
- cancer.gov
It represents the predominant histological subtype of primary liver cancer and most commonly develops in older adults and individuals with underlying chronic hepatic disease
- medlineplus.gov
It represents the predominant histological subtype of primary liver cancer and most commonly develops in older adults and individuals with underlying chronic hepatic disease
- hopkinsmedicine.org
Clinical features frequently include right upper quadrant abdominal pain, hepatomegaly, jaundice, weight loss, or decompensation of preexisting cirrhosis, often alongside elevated serum alpha-fetoprotein levels
Personalize your experience
Follow Liver cell carcinoma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.